Laurus Labs Receives EIR From USFDA For Its FDF & API Integrated Facility

Laurus Labs Ltd has received an Establishment Inspection Report (EIR) (for the Pre-Approval Inspection) from US Food and Drug Administration (USFDA) for its Unit-2 (FDF&API integrated facility) located at APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.

The Pre-Approval Inspection (PAI) was carried out from November 04, 2019 to November 08, 2019.

Shares of Laurus Labs Ltd was last trading in BSE at Rs.399.5 as compared to the previous close of Rs. 403.95. The total number of shares traded during the day was 4473 in over 1004 trades.

The stock hit an intraday high of Rs. 406.4 and intraday low of 394.45. The net turnover during the day was Rs. 1796836.-Equity Bulls